Explore All 633 Divestiture Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 1, 2020 |
| Target | BTG Specialty Pharmaceuticals |
| Sector | Medical Products |
| Buyer(s) | SERB Pharmaceuticals |
| Sellers(s) | Boston Scientific |
| Deal Type | Divestiture |
| Deal Value | 800M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1951 |
| Sector | Life Science |
| Employees | 390 |
SERB Pharmaceuticals is an independent niche specialty pharma company focused on niche branded prescription medicines. The company has a strong focus on therapeutic areas such as critical and emergency care, neurology, diagnostics and endocrinology. SERB Pharmaceuticals was founded in 1951 and is based in Luxembourg.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Medical Products | 1 of 1 |
| Type: Divestiture | 1 of 2 |
| State: Pennsylvania | 1 of 1 |
| Country: United States | 1 of 3 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-07-13 |
Wellstat Therapeutics - Vistogard and Xuriden
Rockville, Maryland, United States Wellstat Therapeutics's Vistogard and Xuriden provides emergency treatment for adult and pediatric patients with hereditary orotic aciduria (HOA)[ii], an ultra-rare, orphan genetic disorder associated megaloblastic anemia as well as failure to thrive, developmental delay, epilepsy, susceptibility to infection, and orotic acid crystals in the urine. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Employees | 48,000 |
| Revenue | 16.7B USD (2024) |
Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
| Deal Context for Seller | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Medical Products | 4 of 4 |
| Type: Divestiture | 5 of 5 |
| State: Pennsylvania | 1 of 1 |
| Country: United States | 6 of 6 |
| Year: 2020 | 2 of 2 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-21 |
Farapulse
Menlo Park, California, United States Farapulse is a developer of a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. Farapulse was founded in 2012 and is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-03 |
Lumenis Surgical Business
Yokneam, Israel Lumenis' Surgical Business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures. |
Buy | $1.1B |
